This supports previous findings that DCN is down-regulated and influences the breast cancer cell motility and invasion, and acts as one of the six-gene signature that adds prognostic value independent of the expression of ER, PR, and HER2 [51, 52]. The gene discussed is ESR1; the disease is breast carcinoma.